CAS 1579965-12-0

GSK2983559 free acid

CAS : 1579965-12-0

GSK2983559 free acid

Degré de pureté : ≥95%

Masse moléculaire : 538.53g/mol

Ref: 54-BUP12812

GSK2983559

CAS : 1579965-12-0

GSK2983559 is a molecule that binds to ferroptosis in inflammatory cells, which are cells that have been stimulated by an external stimulus, such as a bacterial pathogen. It inhibits the production of inflammatory molecules and prevents the release of inflammatory cytokines. GSK2983559 has shown promising results in treating bladder cancer with stricture, with a prognosis of remission and improved quality of life. This drug also has an anti-inflammatory effect on the kidneys and liver and may be effective against kidney cancer. GSK2983559 is not active against cancer cells, but it does inhibit proliferation of cancer cells in culture.

Formule : C₂₁H₂₃N₄O₇PS₂

Degré de pureté : Min. 95%

Masse moléculaire : 538.5 g/mol

Ref: 3D-ENC96512

GSK2983559 free acid

CAS : 1579965-12-0

GSK2983559 free acid selectively inhibits RIP2, reducing inflammatory cytokines in human bowel disease.

Formule : C₂₁H₂₃N₄O₇PS₂

Degré de pureté : 97.8700% - 99.56%

Couleur et forme : Solid

Masse moléculaire : 538.53

Ref: TM-T11492

2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate

CAS : 1579965-12-0

Formule : C₂₁H₂₃N₄O₇PS₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 538.5337

Ref: IN-DA01LIIM